Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan 160 mg Tablets, HDPE 90 cc bottles in cardboard trays, Rx Only, RemedyRepack, Inc., 625 Kolter Drive, Suite 4, Indiana, PA 15701, NDC: 61786-0792-19

D-1101-2018

August 10, 2018

Class II

Product summary

Firm
RemedyRepack Inc.
Event
Event 80827
Status
Terminated
Classification
Class II
Quantity
21 bottles of 90 = 1890 tablets
Official record key
drug-enforcement:D-1101-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lot # B0335344-081717, exp. date 08/2018 Lot # B0363364-110917, exp. date 11/2018 Lot # B0391225-012218, exp. date 01/2019 Lot # B0408458-030618, exp. date 03/2019 Lot # B0384871-010318, exp. date 01/2019 Lot # B0436862-051518, exp. date 05/2019

Distribution pattern: Product was distributed to three customers in FL and VA.

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations